Patents by Inventor Bruna de Andrade Pereira

Bruna de Andrade Pereira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antagonizing CD73 antibody
    Patent number: 11312785
    Abstract: The present invention relates to novel antagonizing antibodies for CD73. The invention also relates to nucleic acids encoding such antibody molecules; to methods for preparing such antibody molecules; to host cells expressing or capable of expressing such antibody molecules; to compositions comprising such antibody molecules; and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: April 26, 2022
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Irmgard Maria Rita Hofmann, Jennifer Ahlberg, Rajkumar Ganesan, Priyanka Gupta, Sven Mostboeck, Simon Plyte, Otmar Schaaf, Chia-Hung Tsai, Melanie Wurm, Markus Zettl, Jark Boettcher, Bruna De Andrade Pereira
  • Antagonizing CD73 Antibody
    Publication number: 20190352420
    Abstract: The present invention relates to novel antagonizing antibodies for CD73. The invention also relates to nucleic acids encoding such antibody molecules; to methods for preparing such antibody molecules; to host cells expressing or capable of expressing such antibody molecules; to compositions comprising such antibody molecules; and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.
    Type: Application
    Filed: May 13, 2019
    Publication date: November 21, 2019
    Inventors: Irmgard Maria Rita HOFMANN, Jennifer AHLBERG, Rajkumar GANESAN, Priyanka Gupta, Sven MOSTBOECK, Simon PLYTE, Otmar SCHAAF, Chia-Hung TSAI, Melanie WURM, Markus ZETTL, Jark BOETTCHER, Bruna DE ANDRADE PEREIRA
  • APC-mediated tolerance induction for therapy of multiple sclerosis
    Patent number: 9592259
    Abstract: The invention relates to transgene expression constructs—particularly self inactivating lentiviral vectors—comprising a dendritic cell specific promoter controlling the expression of autoantigen proteins, namely myelin basic protein, proteolipid protein and myelin oligodendrocyte glycoprotein, for use in the therapy of multiple sclerosis.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: March 14, 2017
    Assignee: University of Zurich
    Inventors: Christiane Dresch, Bruna de Andrade Pereira, Mathias Ackermann, Cornel Fraefel
  • APC-MEDIATED TOLERANCE INDUCTION FOR THERAPY OF MULTIPLE SCLEROSIS
    Publication number: 20140242037
    Abstract: The invention relates to transgene expression constructs—particularly self inactivating lentiviral vectors—comprising a dendritic cell specific promoter controlling the expression of autoantigen proteins, namely myelin basic protein, proteolipid protein and myelin oligodendrocyte glycoprotein, for use in the therapy of multiple sclerosis.
    Type: Application
    Filed: September 26, 2012
    Publication date: August 28, 2014
    Inventors: Christiane Dresch, Bruna de Andrade Pereira, Mathias Ackermann, Cornel Fraefel